Tag: 2021 National Synthetic Biology Roadmap
Synthetic biology advancements propose $30B opportunity for Australia
A collaborative effort between CSIRO and Main Sequence Ventures has unveiled Australia's strides in adhering to ten recommendations outlined in the National Synthetic Biology Roadmap, indicating significant progress towards a potentially lucrative industry.
Featured Article
What spending reveals about downstream consumer demand for manufactured goods
For manufacturers supplying consumer-facing markets, understanding demand conditions has become increasingly important in an environment shaped by cautious spending, rising costs and intense competition.
